Investor Presentaiton slide image

Investor Presentaiton

Addressing disease progression re iTrack™ Advance (mild to moderate) iTrack™ (mid stage) G Molteno3 (Severe and Complex) Glaucoma Nova Eye Current Product Portfolio nova-eye.com | 7
View entire presentation